Geancarlo Zanatta

Dr. Geancarlo Zanatta

Biophysics, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Neuroscience Letters
Verified
Journal Article
Closed access
VBVictorio Bambini-Junior
Victorio Bambini-Junior
Geancarlo ZanattaGeancarlo Zanatta
Geancarlo Zanatta
Gustavo Della-Flora NunesGustavo Della-Flora Nunes
Gustavo Della-Flora Nunes
GMGabriela Mueller de Melo
Gabriela Mueller de Melo
MMMarcus Michels
Marcus Michels
CGCarmem Gottfried
Carmem Gottfried

1 October 2006 in Applied Soil Ecology
Verified
Journal Article
Closed access
RSRené A. Soares
René A. Soares
LRLuiz Fernando Wurdig Roesch
Luiz Fernando Wurdig Roesch
Geancarlo ZanattaGeancarlo Zanatta
Geancarlo Zanatta
FCFlávio A. de Oliveira Camargo
Flávio A. de Oliveira Camargo
LPLuciane Maria P. Passaglia
Luciane Maria P. Passaglia

2 February 2017 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
FLFernanda M. Lopes
Fernanda M. Lopes
LMLeonardo Lisbôa da Motta
Leonardo Lisbôa da Motta
MBMarco A. De Bastiani
Marco A. De Bastiani
BPBianca Pfaffenseller
Bianca Pfaffenseller
BABianca W. Aguiar
Bianca W. Aguiar
FKFabio Klamt
Fabio Klamt

18 November 2014 in Annals of General Psychiatry
Verified
Journal Article
Open access
PDF file
DBDiego Baronio
Diego Baronio
TGTaylor Gonchoroski
Taylor Gonchoroski
KCKamila Castro
Kamila Castro
Geancarlo ZanattaGeancarlo Zanatta
Geancarlo Zanatta
CGCarmem Gottfried
Carmem Gottfried
RRRudimar Riesgo
Rudimar Riesgo
Histamine and its receptors were first described as part of immune and gastrointestinal systems, but their presence in the central nervous system and importance in behavior are gaining more attention. The histaminergic system modulates different processes including wakefulness, feeding, and learning and memory consolidation. Histamine receptors (H1R, H2R, H3R, and H4R) belong to the rhodopsin-like family of G protein-coupled receptors, present constitutive activity, and are subjected to inverse agonist action. The involvement of the histaminergic system in brain disorders, such as Alzheimer’s disease, schizophrenia, sleep disorders, drug dependence, and Parkinson’s disease, is largely studied. Data obtained from preclinical studies point antagonists of histamine receptors as promising alternatives to treat brain disorders. Thus, clinical trials are currently ongoing to assess the effects of these drugs on humans. This review summarizes the role of histaminergic system in brain disorders, as well as the effects of different histamine antagonists on animal models and humans.

10 December 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Geancarlo ZanattaGeancarlo Zanatta
Geancarlo Zanatta
ASAltin Sula
Altin Sula
AMAndrew J. Miles
Andrew J. Miles
LNLeo C. T. Ng
Leo C. T. Ng
RTRubben Torella
Rubben Torella
BWB. A. Wallace
B. A. Wallace
Valproic acid (VPA) is an anticonvulsant drug that is also used to treat migraines and bipolar disorder. Its proposed biological targets include human voltage-gated sodium channels, among other membrane proteins. We used the prokaryotic NavMs sodium channel, which has been shown to be a good exemplar for drug binding to human sodium channels, to examine the structural and functional interactions of VPA. Thermal melt synchrotron radiation circular dichroism spectroscopic binding studies of the full-length NavMs channel (which includes both pore and voltage sensor domains), and a pore-only construct, undertaken in the presence and absence of VPA, indicated that the drug binds to and destabilizes the channel, but not the pore-only construct. This is in contrast to other antiepileptic compounds that have previously been shown to bind in the central hydrophobic core of the pore region of the channel, and that tend to increase the thermal stability of both pore-only constructs and full-length channels. Molecular docking studies also indicated that the VPA binding site is associated with the voltage sensor, rather than the hydrophobic cavity of the pore domain. Electrophysiological studies show that VPA influences the block and inactivation rates of the NavMs channel, although with lower efficacy than classical channel-blocking compounds. It thus appears that, while VPA is capable of binding to these voltage-gated sodium channels, it has a very different mode and site of action than other anticonvulsant compounds.

2 September 2014 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
Geancarlo ZanattaGeancarlo Zanatta
Geancarlo Zanatta
Gustavo Della-Flora NunesGustavo Della-Flora Nunes
Gustavo Della-Flora Nunes
EBEveline Bezerra
Eveline Bezerra
RCRoner Ferreira da Costa
Roner Ferreira da Costa
AMAlice Martins
Alice Martins
CGCarmem Gottfried
Carmem Gottfried